The retinoid X receptors (RXRs) are ligand-activated transcription factors heterodimerize with a number of nuclear hormone receptors, thereby controlling a variety of physiological processes. The invention relates to novel enantiomer compounds which are derivatives of dihydroretinoic acid, their stereoselective synthesis, to pharmaceutical compositions containing the same and to the use of same in the treatment of diseases.
视黄醇X受体(RXRs)是
配体激活的转录因子,与许多核激素受体异源二聚体化,从而控制各种生理过程。本发明涉及一种新型对映体化合物,它们是二氢
视黄酸的衍
生物,它们的立体选择性合成,含有这些化合物的药物组合物以及在治疗疾病中使用这些化合物。